ArticleBioinformation2024
Gingivitis and periodontitis among Indian patients diagnosed using trefoil factor 3.
Article in Bioinformation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently there has been an increased interest on the identifying and preventing the disease with profuse biomarkers. There are very few studies done in understanding the relationship of TFF3 levels in the diseased condition. Therefore, it is of interest to determine effect of non-surgical periodontal therapy on trefoil factor levels in patients with gingivitis and periodontitis. Study sample consisting of 40 subjects of which 20 with gingivitis and 20 with moderate chronic periodontitis were included. The clinical parameters assessed were gingival index, Plaque index, and Probing Depth and Clinical attachment levels. Enzyme linked immunosorbent assay was used to evaluate Serum Trefoil factor 3 (TFF3). Intra group comparisons in gingivitis and periodontitis group have shown that all clinical and biochemical parameters have significantly reduced from base line to 3 months. Increased serum TFF3 concentrations were observed after non-surgical periodontal therapy in both gingivitis and chronic periodontitis group (p<0.001). In conclusion clinical and biochemical analysis of serum TFF3 revealed its influence on periodontal disease activity. Elevated serum Trefoil factor 3 levels showed a strong association with decrease in clinical parameters taken after the therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.